Global Industry News

North America Is Dominating Automated External Defibrillator Industry

The total value of the global automated external defibrillator market was USD 1,677.3 million in 2021, and it will rise at a growth rate of above 8.6% shortly, reaching USD 3,520.5 million by 2030, according to P&S Intelligence. This growth can be ascribed to the improvements in the AED technology, growing count of strategic growths among main players, and increasing occurrence of cardiac illnesses.

To learn more about this report: https://bit.ly/3M3Ub1B

LifeVest uninterruptedly screens the patient’s heart, and in case of the finding of an irregular heart rhythm, generates a shock to bring back the usual heart rhythm. Unlike orthodox counterparts, contemporary implantable cardioverter defibrillators (ICDs) have removed the requirement for inserting a separate pacemaker in patients. Such improvements in technology have impacted the development of the industry.

AEDs used on adult patients held a gigantic revenue share, of approximately 95.6%, in the automated external defibrillator industry, in 2021. This can be credited to the more quickly growing count of adult patients than pediatric patients thought-out the globe.

For example, according to the World Bank, there were approximately 75 million grown-up patients (in the generation of 15 years and above) and 25 million pediatric patients (in the age range of 0–15 years) throughout the globe.

In the coming few years, Pre-hospital care and EMS providers are projected to continue with the dominant in terms of holding the largest share in the automated external defibrillator market. 

The increasing occurrence of SCA and directed the availability of such devices at all pre-hospital-care and emergency sceneries are the main reasons for growing the need for such systems.

In recent years, North America was the largest industry for the automated external defibrillator and held approximately 60% share in the worldwide industry. This can be credited to the better-quality healthcare infrastructure, the existence of well-known players, and the rise in the elderly populace in the continent.

Also, the increasing occurrence of CVDs and the growing count of AED installations have boosted the industry development in North America.

Hence, the improvements in the AED technology, growing count of strategic growths among main players, and increasing occurrence of cardiac illnesses are the major factors driving the automated external defibrillator market.

Share:

Sales of Skincare Devices Set to Explode in Asia-Pacific in Future

The growing prevalence of skin diseases is pushing up the demand for skincare devices across the world. As per the World Health Organization, nearly 132,000 people are diagnosed with melanoma all over the world every year. Furthermore, the organization reported that non-melanoma skin cancer affects between 2 and 3 million people around the world every year. Some of the major reasons behind the high incidence of skin diseases are excessive tobacco and alcohol consumption, anxiety, and stress.

The rising prevalence of skin cancer and various skin problems is also causing a sharp surge in the sales of skin devices across the globe. Besides this, the soaring population of geriatric people is also propelling the global demand for skincare devices. This is because dryness, skin sagging, pigmentary alteration, and wrinkles are highly prevalent among old people, on account of the reduced glandular and vascular network in their skin layers and the loss of fibrous tissue in their skin.

To learn more about this report: https://bit.ly/42IcGjq

Because of the aforementioned reasons, skincare devices and anti-aging devices are increasingly being used by geriatric people. These devices revitalize and tighten their skin and help them attain a youthful look. Apart from these factors, the rapid advancements being made in skincare devices are also propelling the progress of the skincare devices market. Due to these advancements, it is now possible to effectively treat sun spots, cellulite, and fine lines.

For example, Lumenis Ltd. launched Legend Pro+, which is a new face and body platform that provides long-term efficacy, minimal pain, and immediate results without any requirement for anesthesia. Due to these factors, the global skincare devices market is demonstrating rapid advancement. The valuation of the market is predicted to rise from $9,531.9 million in 2019 to $28,157.2 million by 2030. Furthermore, the market is predicted to progress at a CAGR of 11.0% between 2020 and 2030.

Based on application, the skincare devices market is categorized into disease diagnosis & treatment, skin tightening and body contouring, cellulite reduction, hair removal, and skin rejuvenation. Out of these, the hair removal category is predicted to record higher growth in the market in the future years. This is ascribed to the rising public awareness about laser hair removal devices in several countries and the surging requirement for laser hair removal devices around the world. 

Additionally, with rapid expansion in the global e-commerce industry, laser hair removal products for home usage are easily available via various online portals. Geographically, the North American skincare devices market recorded the highest growth in the past, due to the presence of a large population and the high incidence of skin problems in the region. In the future, the market will exhibit the fastest growth in Asia-Pacific (APAC), as per the estimates of the market research company, P&S Intelligence. 

Hence, it is safe to say that the sales of skincare devices will shoot-up all over the world in the forthcoming years, primarily because of the rising prevalence of skin diseases and the surging geriatric population.

Share:

North America Is Dominating Non-Invasive Prenatal Testing Industry

The non-invasive prenatal testing market was valued at USD 3,987.1 million in 2021 and will grow at a rate of about 9.8% during 2021–2030, reaching USD 9,229.2 million by 2030, according to P&S Intelligence.

To learn more about this report: https://bit.ly/41myShv

This development can be credited to the growing occurrence of chromosomal oddities and the increasing need for early discovery approaches. Around, 14% of stillbirths are because of inherited illnesses in pregnant women in the age group of <24 years and the count increases to 38% in women 40–45 years of age.

Of every genetic abnormality, Trisomy 21 had the highest share. Its yearly occurrence is 1 in 800 newborns, which made it the most-frequent chromosomal abnormality in the U.S. In out-and-out terms, in the U.S., more than 5,000 children are born with Trisomy 21 each year.

In 2021, North America had the highest revenue share, of approximately 45%, in the non-invasive prenatal testing market. This can be credited to the robust healthcare infrastructure and technological improvements in the area of diagnostics.

The U.S. is dominating North America and is also projected to develop with a CAGR of 8%, owing to the robust financial backing. Mainly because of the growing occurrence of chromosomal irregularities in the U.S. has led to an increase in the need for prenatal testing.

Since the U.S. offers progressive tests for hereditary conditions, it dominates the regional industry. Additionally, the whole-genome next-generation sequencing technology is being utilized for the purpose in Canada and the U.S. as it provides earlier and more-precise results.

In 2021, the consumables category had the largest share, of more than 60%, because of the presence of a high number of players offering consumables, such as reagents, disposables, and assay kits. The largest share is also credited to the enhancements in the tests for NIPT and a high number of sanctions to numerous assays.

Hence, the growing occurrence of chromosomal oddities and the increasing need for early discovery approaches are the major factors propelling the non-invasive prenatal testing industry. 

Share:

North America Is Driving Animal Healthcare Industry

The global animal healthcare market was valued at USD 40.2 billion in 2022, and this number is projected to reach USD 84.9 billion by 2030, progressing at a CAGR of 9.8% during 2022–2030, as per a report by a market research firm, P&S Intelligence.

To learn more about this report: https://bit.ly/41mJIDX

The growth of the industry can be credited to the snowballing consumption of milk and meat, increasing acceptance of pet animals, and rising frequency of food-borne zoonotic diseases.

In Germany, the veterinary authorities and the regulation together guard animal health. The German government also join forces with the veterinary administration of other EU member states because the transmission of animal viruses across the border is an important issue.

Moreover, pet adoption in Germany is climbing sharply can be credited to the pandemic, with people looking for approaches to fight boredom and loneliness, hence boosting the need for dogs, cats, and other animals.

In 2022, the feed additives category had an animal healthcare market share of approximately 25%. The surge in the consumption of animal-source foods, coupled with the increase in feed production, is the crucial factor fuelling the market growth.

Beef is heavily consumed meat in the U.S., with an average of 67 pounds per person annually. The total demand for animal-source food products is projected to advance by 60% by 2050, while the making of animal proteins is projected to develop by approximately 1.7% annually between 2010 and 2050. Thus, the need for feed additives is predicted to be high owing to the rising demand for nutrient-rich meat products, worldwide.

In the coming years, the companion animals’ category is predicted to advance at a higher CAGR, above 7%. This is mainly because of the snowballing number of companions and growing investment in their well-being. Globally, cat and dog ownership has been increasing progressively.

Some of the communicable diseases, including tuberculosis and bird flu, in vertebrates, can be transported directly or indirectly to humans. If people intake worms through undone or raw, infested fish, they can suffer from anisakiasis, a human zoonotic sickness caused by specific species of nematodes.

In 2022, North America had the largest revenue share, of approximately 35%. The need for feed additives is growing because of the heavy consumption of animal products. The U.S. is the world's major beef producer and prominent exporter as well. To supply nutritive animal-derived food, the need for feed additives is growing in the continent.

Hence, the snowballing consumption of milk and meat, increasing acceptance of pet animals, and rising frequency of food-borne zoonotic diseases, are some major factors that will drive the animal healthcare industry in the future.

Share:

Biopharmaceuticals Industry To be Dominated by North America

The total revenue generated by biopharmaceuticals industry was USD 389.3 billion in 2021, and it will grow at a rate of 7.1% in the years to come, to reach USD 720.8 billion by 2030, as stated by P&S Intelligence.

To learn more about this report: https://bit.ly/41HkDEd

The requirement for biological drugs is on the rise with the growing global occurrence of diabetes, cancer, and cardiovascular diseases. 

By the way, the increasing elderly population and occurrence of related health issues and the thriving requirement for advanced biologic drugs will create a strong growth environment for the players of the industry.

According to a study, biopharma medicines have attained extensive acceptance, credited to the Europe-wide average reductions in price from approximately 8% for anti-TNF biosimilar products to 33– 34% for erythropoietin and G-CSF biosimilars compared to before biosimilars for these drugs were presented.

Furthermore, the effectiveness and safety of bio-based drugs have led to their quick acceptance by people.

North America biopharmaceuticals market held the largest share, with a share of 44%, as a result of the high research and development investments, mounting acceptance of tech advanced solutions, existence of international players, and their efforts to turn up with newer patents. The U.S. holds the main share, followed by Europe and APAC.

Furthermore, the U.S. biopharma industry has fashioned more than 50% of the world’s new molecules in the last ten years, because of the supported government initiatives, intellectual property framework and investments.

Monoclonal antibodies held the  the largest, at 36%, and this will grow at a rate  of about 7.2%, in the years to come. mAbs are the most-significant class of biologics, accounting for above 20% of all the therapeutic candidates authorized by the FDA. Amongst the accepted biologics in 2021, over 15 were mAbs. More than a few mAbs have been accepted for anti-cancer, anti-inflammatory, and other therapeutic uses. 

Precisely, owing to their widely use in cancer treatment, they are becoming predominant in the U.S. and the U.K. 

Likewise, the requirement for anti-inflammatory mAbs is increasing at a good pace. These agents are used for monotherapy or in combination with conservative therapies.

It is because if the booming demand for advanced biologic drugs, the demand for biopharmaceuticals will continue to grow in the years to come.

Share:

Which One Is Best, Digital X-Rays or Traditional X-Rays?

The majority of the time, X-ray devices are painless, noninvasive, and useful for identifying conditions including cancers, fractured bones, and tooth rot. Additionally, it is employed to look for alien objects. As radiation therapy destroys malignant tumors and cells by destroying DNA, X-rays are also employed in treating cancer.

Everyone is now concerned about the rising global burden of chronic illness. About 65 million individuals worldwide suffer from chronic obstructive lung disease, according to the WHO. Whereas employing a variety of imaging modalities to discover the issue early can assist stop it from growing worse.

The public prefers radiography because it is the most widely used, widespread, and economical diagnostic imaging technology. Due to the rising prevalence of chronic illnesses, market participants have been able to spend on medical X-ray equipment research and development.

The X-ray systems market is being driven ahead by a rise in proactive healthcare and testing programs, technological advancements, and an increase in government efforts.

The sector is growing thanks to recent advancements in X-ray systems, including the incorporation of AI into imaging systems, robotics, and portable X-ray systems. These advancements make it now accessible to communities with few resources worldwide.

The major players in the market are adopting several methods, including acquisitions, finance, and product development, to increase their product offerings and capacity.

To learn more about this report: https://bit.ly/42phD06

CT Scanners' Cost-Efficiency with ADC Gain Recognition and Single Chip-Photosensor Array 

The need for affordable CT medical imaging is expanding. Therefore, businesses are working to lower the cost and increase the availability of CT scanners globally.

For instance, ams AG, a pioneer in advanced sensor solutions formerly called Austria Microsystems AG, has launched the release of AS5950. This novel complementary metal oxide semiconductor technology combines a photosensor array with an analog-to-digital converter to simplify deployment and lower the cost of CT medical imaging.

Digital X-Rays Vs. Traditional X-Rays

The first step in screening or diagnosing several health conditions, including pneumonia, is radiography utilizing X-rays. Due to its low cost, X-ray technology is more widely used in the medical industry. It swiftly generates the pictures we need to accurately detect problems, is noninvasive, and is generally safe.

Traditional X-rays, which use film to record pictures of the body's interior components, have been used since the early 1900s. Digital radiography is now a far more effective, affordable, and safe way to create diagnostic pictures because of the integration of computer technology.

If you've ever taken an X-ray taken, you were likely instructed to cover the area around your body from the radiation by wearing a large lead apron or blanket. Although conventional X-rays are safe, digital X-rays emit 80% less radiation.

This indicates that it is improbable that you will experience health problems with infrequent traditional radiation exposure, which is much less likely when using the digital X-ray procedure.

In summary, X-rays are digitally stored on computers and may be viewed on a screen in minutes. The results are normally seen and interpreted by a radiologist, who then provides a statement to the doctor and discusses the findings with you.

Share:

Ventilator Industry IS Dominated by the Adults Category

The ventilator market will grow at a rate of 7.1% in the years to come, to touch USD 2,887.32 million by 2030. This growth has a lot to do with the increasing cases of chronic diseases, such as COPD and asthma globally.

Download report sample at: https://bit.ly/3B8s9wJ

Critical care dominated the industry. This is because of the COVID-19 virus, which has affected a lot of global population. This results in the enormous necessity for critical care, because of a lot of hospitalizations.

Smoking is one of the key reasons of COPD. There are a lot of tobacco users in the low or middle-income nations. As per the CDC, cigarette smoking is a major cause of ailment, debility, and death in the U.S., and it causes for over 480,000 fatalities every year. 

North America dominated the market with over 30% share, in 2021. This is because of the increasing prevalence of respiratory ailments like bronchitis and asthma. 

COPD is perhaps the biggest threat for the people of this region. Likewise, as a result of the advanced healthcare infra in Canada and the U.S., improved ventilator systems are used more often in the region. For example, as per data made available, there were 77,000 ventilators in the hospitals of the country hospitals as of March 2020 and over 8,000 ventilators in the nursing homes of America.

It is due to the increasing count of hospital beds, the demand for ventilators will increase even further by the end of this decade.

Share:

3D Bioprinting Industry To Observe Fastest Growth In Asia-Pacific

The 3D bioprinting industry will reach a value of USD 5,873 million by 2030, propelling at a rate of 19.4%, as per a report by a market research institution, P&S Intelligence.

To learn more about this report: https://bit.ly/3pps5pK

Factors such as the development of 3D biomaterials and bioprinters, the increasing investment by the public and private sectors for bioprinting research activities, and their usage of the same in the cosmeceutical and pharmaceutical industries are positively influencing the industry.

The increasing incidence of chronic disorders and the shortage of organ donors are also boosting the growth of the industry.

The demand for important body parts for transplantation is significantly high. The supply and demand gap for organs and tissues for transplantation is also huge. Kidneys, liver, intestines, heart, and pancreas, are mainly required for transplantation. 

The North American 3D bioprinting market held a share of approximately 40% in recent years. This is credited to the increasing R&D activities, developing healthcare infrastructure, and technological advancements. 

In addition, the increasing elderly population, the increasing incidence of chronic disorders, and the high healthcare expenditure are boosting the demand for this technology in the region. 

Asia-Pacific is expected to witness the fastest growth in the industry, mainly due to the increasing research and development, support and tax benefits by the government, and a large customer base. 

The inkjet technology prints complex tissues and organs on culture substrates by using living cells as bio-inks. The inkjet printers offer high reliability, thus the adoption of these printers in the medical industry has increased significantly.

Some of the key players in the industry are:

1- BICO Group AB

2- Organovo Inc.

3- 3D Systems Corporation

4- regenHU Ltd.

5- Desktop Metal Inc.

6- Cyfuse Biomedical K.K.

7- Tissue Regeneration Systems Inc.

It is due to the high demand for organ and tissue transplants, increasing drug discovery activities, and the increasing elderly population all over the globe, the 3D bioprinting industry will grow significantly in the coming years.

Share:

Point-of-Care Ultrasound Device Industry is Dominated by Europe

As stated in a report by P&S Intelligence, a market research firm, the  point-of-care ultrasound devices market will grow at a rate of 7.9% in the years to come, to reach USD 4,546.5 million by 2030.

To learn more about this report: https://bit.ly/3HOh9bO

The increasing healthcare costs, increasing elderly population, emerging healthcare infra, and growing occurrence of chronic diseases will propel the growth of the industry.

Diagnostic devices will have the larger share in the industry. This has a lot to do with the growing usage of these devices in pericardial effusion, ultrasound for left ventricular systolic function, and severe mitral regurgitation, in addition to pneumothorax, pleural effusion, and pulmonary edema.

Europe had the highest revenue share in the point-of-care ultrasound devices market , and it will be like this in the years to come. The regional market is powered by the high incidence of chronic ailments, growing healthcare spending, and progressions in technology. 

Also, the booming elderly population is driving the growth of the industry in Europe, as it is more vulnerable to diseases.

As per the World Population Ageing 2019, about 140.4 million people were aged 65 years or above in Europe in 2019, and it will reach to a value of 199.9 million by 2050.

The industry is rather fragmented, with the occurrence of more than a few key players. Stalwarts of the market are focusing on strategic partnerships and mergers for being competitive in the market.

It is because of the increasing elderly population, the demand for point-of-care ultrasound devices will continue to grow in the years to come.

Share:

How Does Orthodontics Treatment Enhance Face Aesthetics?

The advancements in the orthodontics have resulted in their increased popularity. There are more people who inquire about orthodontic treatment. It has resulted in effective marketing.

The orthodontic supplies industry has captured $5,206 million revenue in 2021, and it is projected to generate $11,214 million revenue in 2030, advancing at a rate of 8.9% from 2021 to 2030. 

In addition, people undergoing orthodontic treatment, usually have aesthetic goals in their mind. Rising concern about smile enhancement, or appearance results in increasing number of people preferring orthodontic treatment. It is crucial to determine which orthodontic regimen they want to pursue, and offer them clinically sound treatment options. 

People might not be comfortable in having treatment, as per expectations. In such situations, orthodontic specialist referral suits their interest. 

To learn more about this report: https://bit.ly/3NHanYV

Types of Orthodontics Supplies

Dental Mirror

A dental mirror is used for retraction and visualization during performing procedures. 

Straight Probe

A straight probe supports the orthodontic brackets positioning, and it is used to remove the excess composition around brackets, including the removal of elastomeric ligatures from brackets. 

Cotton Pliers

Cotton pliers are used in placing the cotton rolls for isolation, including intra-orally retrieval of small objects. 

Howe Utility Pliers

Howe utility pliers come with pads at the ends. They are used to hold the archwires while performing oral procedures, including their removal and placement. 

Wire Cutter/Pin and Ligature Cutter

A wire cutter, ligature cutter, or pin comes with two tapered beaks with sharp terminal ends. The sharp end’s tip is used to cut small diameter wires, less than 0.015 inches, and cut steel ligatures. 

Distal End Cutters 

The distal end cutters usually come with two cutting surfaces at right angles to the long instrument axis. These are utilized for intra-oral cutting of a ligated archwire’s terminal end. They hold the archwire’s end cut, and thus saves the patient to get hurt or cut by the wire’s end. 

Mathieu Plier

The Mathieu plier possesses quick release locking and unlocking mechanism, that is used for elastomeric ligatures’ placement.

Separating Pliers

Separating pliers are reverse action pliers. They hold the separating modules’ tips. These separators are placed on the pliers’ ends and handle, which are squeezed together to stretch the placement of the separators on teeth. 

Bite Stick

A bite stick is an equipment with a long handle and serrated tip. It can be of various shapes. It is used for positioning the orthodontic bands by utilizing the biting force of the individual. 

Posterior Band Remover

The posterior band remover’s end comes with a flat beak and a nylon-tipped beak. It has a slight curve at the tip. It is used for removing orthodontic bands sitting on posterior teeth. 

Plastic Filling Instrument

It is used for placing composite on the orthodontic bracket’s mesh pad before bonding the bracket. 

Bracket Tweezer 

A bracket tweezer or bracket holder is a reverse-action instrument. It has two fine-angled tips used for positioning orthodontic brackets. 

Therefore, rising concerns to improve smile leads to increased popularity of orthodontic treatments thus, propels orthodontics supply. 

Share:

Nerve Repair and Regeneration Industry is Dominated by North America

The total size of the nerve repair and regeneration market was USD 6.2 billion in 2021, which will reach USD 17.47 billion by 2030, powering at a rate of 12.2% in the years to come, as stated by a report published by P&S Intelligence.

Get more insights: https://bit.ly/424Apd2

Neurostimulation/neuromodulation devices dominated the industry, with more than 64%.  It has a lot to do with the growing count of commercialized SCS products, itself because of the increase in the number of people suffering from injuries related to spinal cord injuries.

Also, the increasing count of applications, tech progressions, and biocompatibility of these devices is driving the size of the category.

Additionally, the growing government funding for the innovation of products and the availability of advantageous reimbursement policies in advanced nations will play a major role in the future.

APAC will have the fastest growth in the future, of more than 13%, in the future, owing to the growing cases of epilepsy, Parkinson’s, Alzheimer’s, and essential tremors; increasing healthcare outlay, and rising geriatric population.

In addition, the acceptance of innovative technologies for the treatment of these diseases is driving regional development. In APAC, the acceptance of nerve regeneration and repair therapies in China, India, and Japan is on a rapid rise because of an increase in the rate of healthcare infra development, and the employment of all the new technologies in these nations.

The increasing number of traumatic brain injuries all over the world has much to do with the increasing demand for nerve repair and regeneration, in the years to come.

Share:

North America Is Dominating HIV Diagnosis Industry

The HIV diagnosis market was valued at $4.13 billion in 2021, and will grow at a rate of about 9.7% in the years to come, for reaching $9.55 billion by 2030.

Get the sample pages of this report: https://bit.ly/3VzLsIJ

The USFDA has permitted a very few numbers of home-based diagnosis kits that can offer HIV test result in 20 to 40 minutes. Such diagnosis kits are majorly used in countries like the U.K. and the U.S.

This method is gaining more popularity because this facility is more cost and time efficient. Also, lots of people are not comfortable to visit any healthcare facility for HIV test even if they observing any symptoms in their bodies which can cause AIDS. 

In 2021, the consumables category held the largest market share of HIV diagnosis market. The main reason behind the growth of this category is rise in the usage of assays, reagents and kits for home as well as laboratory-based analytical tests.

Additionally, consumables needed to be manufactured constantly to fulfil the demand from labs and hospitals. Moreover, several steps have taken by government organizations to control the spread of AIDS, which in turn contributing in the growth of this category.

In terms of size, the antibody test category held the largest market share in 2021, credited to the rise in the number of approvals for new antibody tests with better efficiency and accuracy by several regulatory establishments like, USFDA. Furthermore, the awareness about the disease is growing and technological enhancements are contributing in the growth of the demand for these tests.

North America had the largest HIV diagnosis share, in 2021. This is mainly attributed, because of the high cases of AIDS in the region and also the growing knowledge about it. 

Moreover, this region is considered as the hub for innovations in diagnostic practices as almost all the big players have either headquartered or office here. Also, the growth of this market can be contributed to many funding by government for HIV-related events.

APAC is projected to show the fastest growth with pace of around 11% in coming years. Credited to the increase in the per-capita income of people from this region and low access to antiretroviral therapy. Also, governments are becoming more aware and more cautious about these diseases and taking several steps to stop the spread.

As countries like Indonesia and India becoming more finally stable, they are spending more on the cure of such diseases, which expected to fuel the demand for these products in coming years.

Hence, the industry for HIV diagnosis is boosted by the high count of individuals doing unsafe sex and the growing number of those giving or getting blood.

Share:

Surgical Simulation: What Are Potential Benefits for Healthcare Providers and Patients?

Simulation has long been an important aspect of the aerospace industry, helping train pilots before they get on the actual aircraft. With time, this technique has found acceptance in an increasing number of industries, such as automotive and healthcare. Surgical simulation is a rapidly emerging subsegment of simulation, helping train surgical interns before they actually get to operate on someone. This has become essential because of a perpetually high risk of human error in the operating room, which can cause patients their life and hospitals millions in medical malpractice allegations.

Moreover, even seasoned surgeons are nowadays training on simulators to sharpen their skills. As the medical field witnesses non-stop evolution, so must all doctors. With time, new diseases emerge and the need for better treatments for those known over ages strengthens, which is why even those who have been practicing medicine for 20–30 years must refresh their knowledge and acquire newer skills. Moreover, any medical procedure, however short and seemingly simple, carries risk, which is why many surgeons are now practicing the procedure on a simulator before actually performing it on the living.

To learn more about this report: https://bit.ly/422PLyV

History of Surgical Simulation

Despite sounding really high-tech and almost like the stuff of sci-fi movies, surgical simulation is an ancient technique. The earliest recorded evidence of it is from 600 BC India, where clay and leaf models of the human face were used to practice rhinoplasty, the oldest cosmetic procedure known to man. In medieval times, Ambroise Paré, often credited with revolutionizing surgery, is known to have taken embalmed corpses home, to practice surgical procedures. Later came wooden benchtop models with vaguely realistic impressions and carvings of the insides of the human body.

Modern Simulators for Surgeons

Like almost all fields, the advent of computers and TVs has changed the way surgical simulation works. Corpses are being replaced by high-tech systems with AR and VR technologies. Both kinds of systems use anatomical models of various parts of the human body, to help trainees as well as seasoned doctors sharpen their skills. Some of the ridiculously high-tech surgical simulators even mimic the sounds, smells, and haptic sensations one would feel if working on a living being!

Moreover, the likely unfavorable events one may encounter during an actual procedure, such as respiratory distress, arrhythmia, heart attack, cardiac arrest, stroke, hemorrhage, throat collapse during laryngoscopy or intubation, lung collapse, and seizures, can be created by these systems. This gives users more-extensive training, helping them take the right decision during an actual procedure in quick time. Apart from the simulation of the workings of various organs, these systems also offer audio and visual cues to help people complete the task more efficiently and confidently. Additionally, their software generally comes packed with extensive training modules, which guide users as they train on the system.

Then, there are simpler surgical simulators, which are no different than a videogame, wherein the procedure is conducted in a purely virtual environment, with no anatomical model. These variants are ideal for the initial training process, wherein residents and students need to simply be acquainted with the human anatomy and basic procedures and their terminology. In this regard, the popular videogame Surgery Master can be considered a basic surgical simulator, allowing users to perform more than 10 different procedures. These variants can help acquaint trainees with the step-by-step process in a perfectly safe and fun way.

Additionally, some systems even allow users to practice robot-assisted laparoscopic surgery. Modern healthcare demands proficiency in such procedures as they are painless, shorter, and leave less scarring. Moreover, they are cost-effective and demand a shorter stay at the hospital than open surgeries. As a result, they are becoming rapidly popular among people, especially the elderly and those conscious of their physical appearance. As per an article of January 2020, a study on 169,404 patients in 73 hospitals showed that compared to 1.8% in 2012, over 15% of the surgeries conducted in 2018 were robotic ones.

Moreover, the study showed an 8.8% rise in the volume of such procedures within four years of their introduction by hospitals. Additionally, in 2018, over 35% of the surgeons at the hospitals studied performed robot-assisted surgeries, compared to 8.7% in 2012. Similarly, as per an article published on NCBI, some of the commonest surgical procedures being conducted via robots are hysterectomy, colectomy, and prostatectomy. Since working with robots cannot be taught via traditional live-organism-based methods, modern simulators are essential for this purpose.

Patient-Specific VR Simulators and 3D Rapid Prototyping: Latest Advances in Surgical Simulation

Taking surgical simulation one step further into the future are systems that combine patient data on the disease and specific body response to therapy, to virtually create an environment that surgeons would encounter in reality. This allows healthcare professionals to plan the surgery better and improve patient outcomes. With 3D rapid prototyping, MRI and CT scans are used to create 3D-printed models of the patient anatomy, simulating the actual disease, for the doctor to practice the procedure.

Similarly, patient-specific VR simulation creates a virtual model of the disease or tissue as it functions within the patient’s body, which not only allows doctors to practice the procedure but also for effective information sharing among team members, which can ultimately reduce human error in the OR and improve the overall patient outcome. As claimed by the companies offering these simulators, their accuracy in using CT and MRI images to virtually create the patient anatomy ranges between 95% and 100%.

Impact of Surgical Simulation on Patients and Hospitals

The key aims of using simulations (low- or high-fidelity) for surgical training are to quicken the actual procedure, reduce human error, and enhance collaboration and communication in the OR, to ultimately improve patient outcomes. In this regard, 14 studies done on clinical trials were analyzed and assessed and the results published on NCBI. The assessment showed significant improvements in clinical outcomes for patients on whom the surgery was conducted after proper simulation-based training over those on whom the surgery was conducted without any prior surgical training, in four of the studies.

Similarly, as per an article published on the website of the Society of American Gastrointestinal and Endoscopic Surgeons (SAGES), randomized VR simulation trials on junior surgical residents showed a 29% decrease in laparoscopic cholecystectomy duration and that residents who received the training were nine times less likely to stall during the procedure and five times less likely to injure the gallbladder or cauterize unintended tissue. This is confirmed by a study published in the Journal of Neurosurgery of the American Association of Neurological Surgeons in March 2021 that showed that post-simulation-based training, surgeons achieved an over 90% efficiency in treating internal carotid artery injury (ICAI), with the time to hemostasis and estimated blood loss reducing by 38 and 37%, respectively.

As per another study done at a community hospital in the U.S., the addition of a third-year resident to the OR can increase the surgery time by around 44 minutes, as the procedure needs to be slowed to train the resident. Moreover, simulation-based surgical training can reduce the per-minute OR expense, which is usually around $20 for the hospital and up to $60 for the patient. One study showed a decrease of over $700,000 in annual hospital expenses by imparting better and quicker training to residents and reducing the incidence of catheter-related bloodstream infections in the ICU.

Hence, with the multitude of benefits of surgical simulation for patients and hospitals, the popularity of this technique continues to grow, spurred by the increasing concerns related to medical malpractice and widening lack of OR space to train residents. Additionally, the advent of newer surgical techniques mandates even experienced surgeons to add to their repertoire of skills, with the ultimate aim to improve patient outcomes and reduce costs.

Share:

North America Is Dominating Surgical Robots Industry

The size of the international surgical robots market was USD 6,281.1 million in 2021, and the figure is set to rise at a CAGR of 19% in the duration of 2021–2030 and reach USD 30,067.2 million by the end of this decade, as per P&S Intelligence. This growth can be credited to the growing requirement for knee and hip replacement operations and the rising technological improvements.

In the coming few years, the neurology category is predicted to witness the fastest development, growing at a CAGR of approximately 21%, in the surgical robots industry. This can be mainly credited to the technological improvements in robotic brain operations and the rising utilization of medical robots for offering treatment to patients suffering from brain conditions.

Furthermore, the industry in this category is rising because of the occurrence of neurological syndromes and the growing demand for minimally invasive methods for conducting delicate brain operations.

On the basis of end-users, the hospital category is dominating the surgical robots market. This can be credited to the huge count of operations conducted in such healthcare amenities, worldwide. With the surge in the occurrence of chronic illnesses among the populace, the count of operations rises in hospitals.

Furthermore, the existence of sophisticated hospitals in nations including Canada and the U.S. and their supportive results surges the footfall in such settings, because of the utilization of progressive technologies, like robotics.

Hence, the growing requirement for knee and hip replacement operations and the rising technological improvements, are the major factors propelling the surgical robots industry.

Share:

North America Air Quality Monitoring Industry Is Driven by Rising Pollution Levels

Air quality monitoring denotes the constant measurement of precise air pollutants also called “criteria air pollutants”. Arranging air pollution info together with natural background/trace gas monitoring and stationary source emission monitoring supports defining what type of air pollution individuals are unprotected to.

Air pollution monitoring info is crucial for air pollution calculation, countermeasures, and environmental pollution guidelines by local and national establishments, private and public businesses, and national governments.

The North American air quality monitoring market is driven by a strict governing framework for decreasing air pollution levels, growing knowledge about the harmful impacts of air pollution, and a hike in air pollution levels in the continent.

To learn more about this report: https://bit.ly/42fMvjh

Understanding the Air Quality Index

The Air Quality Index was developed by the U.S. Environmental Protection Agency (EPA) to offer an easy, even method to account for daily air quality situations. Minnesota AQI numbers are resulted by hourly quantities of five toxins:

Fine particles

Ground-level ozone

Sulfur dioxide

Nitrogen dioxide

Carbon monoxide

The toxin with the uppermost AQI value shows the general AQI for that hour. The MPCA offers daily air quality forecasts for levels of tiny particles and ground-level ozone (from April through October) in 18 sites in Minnesota. When the forecast is for AQI values to be close or to surpass 101, an air quality alert is allotted.

North America Air Quality Monitoring Market Competitive 

Main companies in the North American air quality monitoring industry are spending on acquisitions to get a larger share of the industry. For example, in December 2017, Thermo Fisher Scientific Inc. finalized the acquisition of certain assets of EPTEK Technology Co. Ltd. and numerous of its associated entities with offices in Taiwan and mainland China. The assets attained contain VOC continuous emission monitoring systems, utilized to measure and analyze air quality across a variety of industrial applications.

The industrial uprising has not only cemented a way for better technology but has also led to issues related to air pollution. Individuals existing in high-polluted zones are more expected to be impacted by the tumorous disease compared to individuals living in a zone with a controlled quality environment.

Hence, a strict governing framework for deceasing air pollution levels, growing knowledge about the harmful impacts of air pollution, and a hike in air pollution levels in the continent are the major factors propelling the North American air quality monitoring industry.

Share:

Medical Device Outsourcing Industry IS Dominated by North America

The medical device outsourcing market had the size of USD 112.1 billion in 2022, and this will reach USD 273.0 billion by 2030, powering at a at a rate of 11.8% by the end of this decade, as per a market research report by P&S Intelligence.

To learn more about this report: https://bit.ly/44mPUyM

Contract manufacturing is a conventional technique for outsourcing medical devices. Though access to inexpensive labor is the reason, producers outsource production, the major factor for contract medical product manufacturing is less time taken for marketing the products.

Furthermore, outsourcing numerous production phases to many partners reduces the total time taken for developing new devices or products.

Regulatory process for the product commercialization has become more intense and rigorous, because of the incessant development of the medical device industry. 

The regulatory compliance outsourcing is becoming popular in the industry since the providers help the manufacturing companies for getting timely launch/approval of their products with numerous other advantages, including reduced cost, more time for the organization’s staff toward core activities, and easy penetration of the market in other nations.

The cardiology category dominates the industry. This is because of the escalating count of CVDs, such as atrial fibrillation, myocardial infarction, angina pectoris, hypertensive heart disease, rheumatic heart disease, and congenital heart disease; and increasing surgical procedures.

Moreover, because of the substantial intricacies of CVD devices, increasing requirement for technical knowhow, and production of these kinds of products might bring about high cost to the OEMs, resulting in the higher rate of outsourcing.

The plastic surgery category will grow the fastest in the future. This has a lot to do with the growing count of minimally invasive aesthetic surgeries and growing number of products for outsourcing. 

Moreover, the obtainability of skilled outsourcing providers adhering to regulatory criteria and the increasing requirement for cosmetic procedures are mainly responsible for the growth of the category.

Contract manufacturing had the largest revenue share in the medical device outsourcing market, of about 30%, in 2022, and will continue to do so in the years to come.

This is because of the increasing requirement for medical components for many applications, growing preference for good and safe equipment for patient care, and mounting necessity for services, for example laser processing, precision grinding, stamping, and milling, insert molding & turning to design a comprehensive device.

North America was the market dominator, with a revenue share of about 40%, and it will maintain its position in the years to come. 

This is because of the wide use of pioneering technology, the existence of numerous medical device manufacturers outsourcing some of their regulatory and consulting purposes to regulatory service providers, growing minimally invasive and noninvasive processes, and the increase in capital spending on healthcare.

It is because of the continuous technological advancements going around the world, the demand for medical device outsourcing is on the rise.

Share:

Intraoperative Neuromonitoring Industry Is Dominated by North America

The intraoperative neuromonitoring market is expected to advance at a rate of 4.8%, to reach USD 4.93 billion by 2030 as per a report by P&S Intelligence.

Get the sample pages of this report: https://bit.ly/3AIr9zo

This growth is credited to the increasing incidence of various lifestyles-related diseases, the rising demand for advanced intraoperative neuromonitoring and minimally invasive devices, and the growing focus on the safety of the patient during complex surgeries.

Insourced monitoring dominated the market, with approximately 52% revenue share, in recent years and it will remain dominant in the years to come. This is because of the rising demand for consistent monitoring, increasing acquisitions by device manufacturers, and growing number of surgical cases.

North American intraoperative neuromonitoring market held the largest revenue share, of approximately 51%, and it will remain dominant in the future. This is credited to the rising rate of IONM adoption, the advantageous reimbursement framework for such neuromonitoring solutions, the growing consciousness for neurological monitoring, the high incidence of neurological disorders, and the existence of developed healthcare infrastructure. 

APAC will witness the fastest growth in the coming years. This is attributed to the increasing elderly population, the large number of healthcare reforms, the increasing incidence of chronic disorders, and the growing demand for advanced healthcare services in China and India. 

Due to the increasing technological advancement, and increasing research and development expenditures, the intraoperative neuromonitoring industry will grow substantially in the coming years.

Share:

Expansion of Biopharmaceuticals Sector Boost Demand for Cell Isolation

Cell isolation is also known as cell separation or cell sorting. It is a process of isolating one cell population from other cells in a heterogeneous biological sample. The targeted cells are isolated and separated.

Cell separation and isolation techniques are utilized for detecting diseases early, and in biopharmaceutical production, such as biosimilars, recombinant proteins, and monoclonal antibodies. Cell isolation is highly utilized in the healthcare sector, due to the hassle-free production of biopharmaceuticals.

Cells require a more scrutinized filtration system as they are obtained from humans, plants, and animals, to prevent contamination from bacteria and viruses. It thus helps in improving the treatment of patients.

Biopharmaceuticals are utilized in chronic disease treatment, more specifically cancer. The growing prevalence of cancer and other chronic diseases has resulted in increased biopharmaceutical demand. Biopharmaceuticals help in the early diagnosis of cancer. 

Moreover, monoclonal antibodies are utilized for targeting the antigens and irregular pathways present in cancer cells. The early detection of cancer helps in saving the lives of millions of people around the world.  

The expansion of the biopharmaceutical industry due to the massively growing population in emerging countries, such as India and China, leads to the growing demand for cell isolation biological structures.

To learn more about this report: https://bit.ly/44mnC7u

The cell isolation techniques support scientists in performing various applications, such as,

Capturing tumor cells in the blood

Isolating immune cells in peripheral blood

Isolating the white blood cells from tissue

Separation of bacteria from food

conducting molecular analysis of specific cell populations

recovering the mononucleated cells from blood

Cell Isolation Techniques 

There are several types of methods for isolating cell populations, these are usually based on one or more properties unique to the cell type such as density, protein, electric charge, size, expression, and others. 

Fluorescence-Activated Cell Sorting 

The fluorescence-activating cell sorting technology involves labeling cells with fluorescent markers depending on the targeted cell group’s internal or external characteristics. Based on the color, the cells are identified and sorted one at a time. 

Density Gradient Centrifugation 

The density gradient centrifugation involves centrifugation of the biological sample until cell types are isolated into layers based on their specific densities. 

Magnetic-Activated Cell Sorting (MACS)

The magnetic-activated cell sorting involves binding magnetic particles to cells through an antibody interaction with the surface markers of targeted cells. Further, the cell group is magnetically isolated from the rest of the biological sample. 

Filtration

It is a cell isolation method that depends on the cell size. It utilizes a filtration device that is specific to the size of the targeted cell group. The smaller cells pass-through the device, while the larger ones are trapped. 

Buoyancy-Activated Cell Sorting (BACS)

The buoyancy-activated cell sorting involves revolutionary cell isolation technology. In this, microbubbles bind to cells, while the targeted cells are removed through floatation. 

The major companies operating in the industry are Merck KGaA, Terumo Corporation, STEMCELL Technologies Inc., Dickinson and Company, Bio-Rad Laboratories Inc, Thermo Fisher Scientific Inc., and Becton. 

Therefore, the expansion of the biopharmaceutical sector in emerging economies leads to the growing demand for cell isolation to improve healthcare.

Share:

Skin Substitutes Led the Wound Care Biologics Industry

As per a statement by a market research firm, P&S Intelligence, wound care biologics market is experiencing growth, and it will continue to grow in the years to come.

To learn more about this report: https://bit.ly/41T36JN

North America will be the leader of the industry. This has a lot to do with the increasing elderly population, innovation in wound care biologics, augmented contribution of private and public organizations in increasing consciousness on wound care, and the increasing count of burn cases. 

Furthermore, the increasing occurrence of ulcers and growing keenness of patients for cutting-edge wound care products that have negligible side-effects and graft rejection are resultant in the high acceptance of wound care biologics in the region.

The industry will grow the fastest in the APAC region, mostly because of tech innovations, increasing  elderly population, increasing count of burn cases and traumatic wounds, and increasing occurrence of chronic wounds. Asa per the World Population Ageing 2017, Asia witnessed a two-fold increase in its elderly population, with the people over the age of 60 years will reach to about 1.3 billion by 2050. 

Increasing use of permanent and temporary skin substitutes and increasing requirement for combination dressings, for instance, silver collagen and collagen hydrochloride for the prevention of microbial infection in injured areas are the main trends of the wound care biologics market. 

Also, growing emphasis of pharma and biotech companies on new biologics is subsequent in the expansion of new, improved products that are providing support to the wound care specialists for the treatment of the acute and chronic wounds, which comprises of venous leg ulcers, diabetic foot ulcers, pressure ulcers, and surgical and burn injuries, in an improved way. 

It is because of the increasing elderly population and the increasing count of surgeries happening all over the world, the demand for wound care biologics will continue to grow in the years to come.

Share:

Anastomosis Devices Industry Is Dominated by the North American Region

The total revenue generated by the anastomosis devices market was USD 2,912.7 million in 2022, which will reach USD 5,535.1 million by 2030, powering at a compound annual growth rate of 8.5% by the end of this decade, as stated by P&S Intelligence, a market research company.

To learn more about this report: https://bit.ly/40SP9u0

The disposable category had the larger share of revenue, about 80%, in the past. This is because of an extensive range of these items being obtainable and increased penetration of the marketplace. Furthermore, numerous industry players manufacture disposable items.

Also, these products reduce the possibility of SSI, cross-contamination, and further infections associated with healthcare. These instruments also have the advantage of not requiring to be reprocessed in between applications, lowering the cost of reprocessing and accelerates the overall procedures. Hence, the said advantages will power this category steadily.

The cardiovascular and thoracic surgeries category had the largest share of revenue, over 60%. This is owing to the constant increase in the occurrence of CVDs, which are a main contributor to the increase in the heart surgery count. As per the WHO, there are about 17.9 million deaths happen because of CVDs.

Alternatively, because of the increasing frequency of colorectal cancer and other gastrointestinal ailments that require bowel resection, the gastrointestinal surgeries category, including large bowel resections and colorectal procedures, will experience considerable growth rate of approximately around 10% in the near future.

North America dominated the anastomosis devices market with 45%. Multiple CVD indications, for example CAD and strokes, and gastric malignancies, including lymphoma and adenocarcinoma, are becoming more predominant in the region, leading to an increase in procedures and a following increase in the requirement for anastomosis systems.

There is an increase in the number of target illnesses all over the world, that is why the demand for anastomosis devices in the market will be on the rise in the years to come.

Share:

Follow Me

Powered by APSense.com

Follow Me

Follow on LinkedIn

Followers

Total Pageviews

Popular Posts

Recent Posts

Label Cloud